Abstract
BackgroundGuidelines recommend cardiovascular (CV) preventive pharmacotherapy when the CV risk evaluated by SCORE is ≥5% (primary prevention), and after diagnosed CV disease (secondary prevention). Undertreatment and poor goal attainment of...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
